Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PD-1 inhibitor as bridge therapy to liver transplantation?

Literature DB >> 33316117

PD-1 inhibitor as bridge therapy to liver transplantation?

Parissa Tabrizian¹, Sander S Florman¹, Myron E Schwartz¹.

Abstract

Entities: Disease Gene Species

Keywords: cancer/malignancy/neoplasia; clinical research/practice; graft survival; immunobiology; liver disease: malignant; liver transplantation/hepatology

Year: 2021 PMID： 33316117 DOI： 10.1111/ajt.16448

Source DB: PubMed Journal: Am J Transplant ISSN： 1600-6135 Impact factor: 8.086

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Stable liver graft post anti-PD1 therapy as a bridge to transplantation in an adolescent with hepatocellular carcinoma.

Authors: Elise Kang; Mercedes Martinez; Hanna Moisander-Joyce; Yvonne M Saenger; Adam D Griesemer; Tomoaki Kato; Darrell J Yamashiro; Helen Remotti; Robyn D Gartrell
Journal: Pediatr Transplant Date: 2021-12-15

2. Toxicity Profiles of Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.

Authors: Christopher D Griffiths; Betty Zhang; Kasia Tywonek; Brandon M Meyers; Pablo E Serrano
Journal: JAMA Netw Open Date: 2022-07-01

3. Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant.

Authors: Chimaobi M Anugwom; Thomas M Leventhal; Jose D Debes
Journal: Hepatoma Res Date: 2022-02-11

Review 4. Liver transplantation for hepatocellular carcinoma following checkpoint inhibitor therapy with nivolumab.

Authors: Gabriel T Schnickel; Kassandra Fabbri; Mojgan Hosseini; Michael Misel; Jennifer Berumen; Justin Parekh; Kristin Mekeel; Yalda Dehghan; Yuko Kono; Veeral Ajmera
Journal: Am J Transplant Date: 2022-02-08 Impact factor: 9.369

Review 5. Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View.

Authors: Maen Abdelrahim; Abdullah Esmail; Ashish Saharia; Ala Abudayyeh; Noha Abdel-Wahab; Adi Diab; Naoka Murakami; Ahmed O Kaseb; Jenny C Chang; Ahmed Osama Gaber; Rafik Mark Ghobrial
Journal: Cancers (Basel) Date: 2022-03-30 Impact factor: 6.575

Review 10. Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors.

Authors: Qimeng Gao; Imran J Anwar; Nader Abraham; Andrew S Barbas
Journal: Cancers (Basel) Date: 2021-12-15 Impact factor: 6.639

PD-1 inhibitor as bridge therapy to liver transplantation?

1. Stable liver graft post anti-PD1 therapy as a bridge to transplantation in an adolescent with hepatocellular carcinoma.

2. Toxicity Profiles of Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.

3. Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant.

Review 4. Liver transplantation for hepatocellular carcinoma following checkpoint inhibitor therapy with nivolumab.

Review 5. Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View.

6. Immune Checkpoint Inhibitor Therapy Before Liver Transplantation-Case and Literature Review.

Review 7. Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons.

Review 8. Liver Transplantation for Hepatocellular Carcinoma: How Should We Improve the Thresholds?

Review 9. Upper Limits of Downstaging for Hepatocellular Carcinoma in Liver Transplantation.

Review 10. Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors.